Career Enhancement in Myasthenia Gravis research
Official title: Career Enhancement
Funded at George Washington University · NIH-11414979 · Data updated 2026-11-12
This grant helps researchers who study myasthenia gravis build skills in clinical trials, biomarkers, and translational science to develop better treatments.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | George Washington University NIH-funded |
| Lab location | 1 site (Washington, United States) |
| Project start | September 1, 2019 |
| Project end | August 31, 2030 |
| Funding year | 2026 |
| Award (this year) | $114,030 |
| NIH project number | 5U54NS115054-07 |
| Project ID | NIH-11414979 on NIH RePORTER |
Who could benefit from this research
✓Could help
Not applicable to patients directly; designed for researchers pursuing MG-related clinical/translational work.
✕Less likely to help
No direct patient participation expected in this training-focused grant.
What this research studies
MGNet’s Career Enhancement Core funds mentored apprenticeships across several institutions to grow researchers’ expertise in MG-focused clinical studies and biomarker work. The program emphasizes hands-on training, strong mentorship, and career development to help scholars become independent investigators. Participants will engage in research activities at CTSAs and related sites, gaining experience in trial design, biomarker discovery, and translational methods. The long-term aim is to nurture a new generation of MG researchers who can advance therapies for this rare disease.
Why it matters
Potential benefit: If successful, patients with MG could benefit from more effective treatments developed by well-trained researchers.
How similar studies have gone: Previous mentorship programs in clinical/translational MG research have shown participants advancing to independent investigator roles.
Where this research is happening
-
George Washington University
Washington, United States Active
Researchers
- Principal investigator: Statland, Jeffrey — George Washington University
- Study coordinator: Statland, Jeffrey
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.